CytomX Therapeutics, Inc.
CTMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001501989
No open-market purchases or sales by CytomX Therapeutics, Inc. insiders were filed in the last 90 days; 178 institutions reported holding it in 13F filings for Q2 2026, worth $799.0M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in CytomX Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 84
- −15 vs. Q2 2022
- Shares held
- 36.3M
- −9.26M (−20.3%) vs. Q2 2022
- Total value
- $52.6M
- −$30.8M (−36.9%) vs. Q2 2022
- New holders
- 10
- 23 more added
- Sold out
- 25
- 24 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 178 | $799.0M |
| Q1 2026 | 179 | $911.2M |
| Q4 2025 | 122 | $613.9M |
| Q3 2025 | 103 | $438.4M |
| Q2 2025 | 83 | $302.6M |
| Q1 2025 | 66 | $28.8M |
| Q4 2024 | 70 | $48.1M |
| Q3 2024 | 69 | $60.4M |
| Q2 2024 | 74 | $61.9M |
| Q1 2024 | 88 | $97.1M |
| Q4 2023 | 68 | $50.6M |
| Q3 2023 | 62 | $41.8M |
| Q2 2023 | 67 | $58.7M |
| Q1 2023 | 76 | $53.7M |
| Q4 2022 | 81 | $57.5M |
| Q3 2022 | 84 | $52.6M |
| Q2 2022 | 99 | $83.4M |
| Q1 2022 | 119 | $143.4M |
| Q4 2021 | 110 | $236.5M |
| Q3 2021 | 114 | $274.8M |
| Q2 2021 | 122 | $358.9M |
| Q1 2021 | 126 | $422.2M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding CytomX Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Clear Harbor Asset Management, LLC | 0 | $0 | 0.00% | −11,440−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −9,346−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −1,245−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −445−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −429−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −201−100.0% | Sold out |